banner
JAK inhibitor Abrocitinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ352

JAK inhibitor Abrocitinib, Purity ≥98%

Synonym: Abrocitinib; 1622902-68-4; PF-04965842; Cibinqo; N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide; JAK inhibitor

  • MDL: MFCD30187577
  • CAS Number: 1622902-68-4
  • Compound CID: 78323835
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Abrocitinib, soluble in DMSO and insoluble in ethanol and water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, and Tyk2.
Molecular Weight
323.415
Molecular Formula
C14H21N5O2S
Targets
JAK1: 29 nM; JAK2: 803 nM; Tyk2: 1253 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 58 mg/mL (179.34 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Abrocitinib is used to explore JAK1 inhibition for the treatment of autoimmune and inflammatory diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0